Cholestatic and non-alcoholic fatty liver disease share several key pathophysiological mechanisms which can be targeted by novel therapeutic concepts that are currently developed for both areas.
[Gut]
7992332
{7992332:AAAAAAAA}
apa
50
1
167624
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
